{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:12:50Z","timestamp":1758474770957,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Primary immune thrombocytopenia is an autoimmune bleeding disorder characterized by variable immune-mediated platelet destruction. These patients have reported thrombotic complications, both venous and arterial, in addition to bleeding. Splenectomy and thrombopoietin receptor agonists are recommended for patients who do not respond to steroids or immunosuppressive treatments. Chronic thromboembolic pulmonary hypertension is a rare disease that results from a persistent, organized thromboembolic obstruction of the pulmonary arteries due to an incompletely resolved pulmonary embolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentations<\/jats:title><jats:p>We report two cases of chronic thromboembolic pulmonary hypertension induced by a thrombotic mechanism after treatment with splenectomy and Eltrombopag, a thrombopoietin receptor agonist, for refractory primary immune thrombocytopenia. Consequently, the patients were referred for surgical pulmonary thromboendarterectomy therapy as suggested.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In older patients, those with a history of thrombotic manifestations, or those with high-risk factors, clinicians should evaluate and monitor the risk of thrombotic events and chronic thromboembolic pulmonary hypertension when treating primary immune thrombocytopenia with splenectomy and Eltrombopag.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1508574","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:30:01Z","timestamp":1739345401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Roberto","family":"Castelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro Palmerio","family":"Delitala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore Antonio","family":"Masala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Micheluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Ponti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dante","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gidaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Donadoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Merella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicia Isabella","family":"Profili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Maria","family":"D'Armini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cei.13475","article-title":"Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course","volume":"201","author":"Castelli","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/jth.14227","article-title":"Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults","volume":"16","author":"Piel-Julian","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11239-020-02083-x","article-title":"Risk of thrombosis in elderly immune primary trombocytopenic patients treated with thrombopoietin receptors agonists","volume":"50","author":"Castelli","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0140-6736(10)60959-2","article-title":"Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study","volume":"377","author":"Cheng","year":"2011","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood-2017-04-748707","article-title":"Safety and efficacy of long-term treatment of chronic\/persistent ITP with eltrombopag: final results of the EXTEND study","volume":"130","author":"Wong","year":"2017","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjh.13787","article-title":"Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study","volume":"174","author":"N\u00f8rgaard","year":"2016","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/hematolrep15040069","article-title":"Platelet microvesicles, inflammation, and coagulation markers: a pilot study","volume":"15","author":"Gidaro","year":"2023","journal-title":"Hematol Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/ejh.14154","article-title":"Risk-based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP)","volume":"112","author":"Lambert","year":"2024","journal-title":"Eur J Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.medcli.2023.08.006","article-title":"Update in the management of chronic thrombo-embolic pulmonary hypertension","volume":"162","author":"Ribas Sola","year":"2024","journal-title":"Med Clin"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e038385","DOI":"10.1136\/bmjopen-2020-038385","article-title":"Association between splenectomy and chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.thromres.2024.04.027","article-title":"Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes","volume":"238","author":"Fyksen","year":"2024","journal-title":"Thromb Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jth.13970","article-title":"The influence of thyroid function on the coagulation system and its clinical consequences","volume":"16","author":"Elbers","year":"2018","journal-title":"J Thromb Haemostasis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ajh.10253","article-title":"Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)","volume":"72","author":"Schwartz","year":"2003","journal-title":"Am J Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4149\/BLL_2024_28","article-title":"Risk of chronic thromboembolic pulmonary hypertension after splenectomy","volume":"125","author":"Bollova","year":"2024","journal-title":"Bratisl Med J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/thx.2004.038083","article-title":"Splenectomy and chronic thromboembolic pulmonary hypertension","volume":"60","author":"Ja\u00efs","year":"2005","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1513\/AnnalsATS.201512-826FR","article-title":"Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension","volume":"13","author":"Kimmig","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/ph16060868","article-title":"The outcomes and adverse drug patterns of immunomodulators and thrombopoietin receptor agonists in primary immune thrombocytopenia Egyptian patients with hemorrhage comorbidity","volume":"16","author":"Hamed","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood.2021010968","article-title":"How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment","volume":"137","author":"Ghanima","year":"2021","journal-title":"Blood"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1508574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:30:03Z","timestamp":1739345403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1508574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":24,"alternative-id":["10.3389\/fcvm.2025.1508574"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1508574","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"article-number":"1508574"}}